Dopamina - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 24,143 | 28,856 | 30,204 | 26,008 | 26,188 | 26,720 | 32,466 | 9,427 |
| Profit before tax | 0 | 7,473 | 7,567 | 367 | 103 | 250 | 100 | -1,038 |
| Net profit | 0 | 7,099 | 7,189 | 349 | 98 | 237 | 100 | -1,038 |
| Equity | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | 2,500 | 2,600 | 2,600 |
| Liabilities | 0 | 19 | 378 | 18 | 5 | 13 | 0 | 0 |
| Non-current assets | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 |
| Current assets | 2,499 | 2,518 | 2,877 | 2,517 | 2,504 | 2,512 | 2,600 | 2,600 |
| Total assets | 2,500 | 2,519 | 2,878 | 2,518 | 2,505 | 2,513 | 2,600 | 2,600 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,090 | 1,562 | 297 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -16.8% | +19.5% | +4.7% | -13.9% | +0.7% | +2.0% | +21.5% | -71.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 281.8% | 249.8% | 13.9% | 3.9% | 9.4% | 3.8% | -39.9% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 284.0% | 287.6% | 14.0% | 3.9% | 9.5% | 3.8% | -39.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 0.0% | 24.6% | 23.8% | 1.3% | 0.4% | 0.9% | 0.3% | -11.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 0.0% | 25.9% | 25.1% | 1.4% | 0.4% | 0.9% | 0.3% | -11.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 6,898 | 14,428 | 15,102 | 13,004 | 13,094 | 13,360 | 16,233 | 4,714 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dopamina - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-23 | 2026-08-23 | 307.68 |
| 2026-08-19 | 2026-08-19 | 307.68 |
| 2026-08-16 | 2026-08-17 | 1.12 |
| 2026-08-04 | 2026-08-14 | 1.12 |
| 2026-07-27 | 2026-08-03 | 35.72 |
| 2026-07-26 | 2026-07-26 | 129.56 |
| 2026-07-23 | 2026-07-25 | 96.08 |
| 2026-07-21 | 2026-07-22 | 294.96 |
| 2026-07-19 | 2026-07-20 | 329.56 |
| 2026-07-16 | 2026-07-17 | 329.56 |
| 2026-05-18 | 2026-05-31 | 42.05 |
| 2026-05-17 | 2026-05-17 | 321.89 |
| 2026-05-03 | 2026-05-14 | 42.05 |
| 2026-04-27 | 2026-04-29 | 42.05 |
| 2026-04-26 | 2026-04-26 | 39.84 |
| 2026-04-23 | 2026-04-25 | 42.05 |
| 2026-04-20 | 2026-04-22 | 39.84 |
| 2026-03-27 | 2026-03-27 | 279.84 |
| 2026-03-17 | 2026-03-22 | 279.84 |
| 2026-02-18 | 2026-02-18 | 279.84 |
| 2026-01-21 | 2026-01-27 | 505.76 |
| 2026-01-16 | 2026-01-20 | 503.20 |
| 2026-01-01 | 2026-01-15 | 248.36 |
| 2025-12-30 | 2025-12-30 | 248.36 |
| 2025-12-16 | 2025-12-29 | 254.84 |
| 2025-11-18 | 2025-11-20 | 256.00 |
| 2025-10-23 | 2025-11-17 | 1.16 |
| 2025-10-16 | 2025-10-19 | 254.84 |
| 2025-09-16 | 2025-09-18 | 254.84 |
| 2025-08-28 | 2025-08-29 | 255.54 |
| 2025-08-19 | 2025-08-21 | 255.54 |
| 2025-07-24 | 2025-08-18 | 0.70 |
| 2025-07-16 | 2025-07-23 | 255.21 |
| 2025-06-19 | 2025-07-15 | 0.37 |
| 2025-06-17 | 2025-06-18 | 255.21 |
| 2025-06-11 | 2025-06-16 | 0.37 |
| 2025-06-08 | 2025-06-09 | 0.37 |
| 2025-05-18 | 2025-06-04 | 0.37 |
| 2025-05-16 | 2025-05-17 | 255.21 |
| 2025-05-04 | 2025-05-15 | 0.37 |
| 2025-04-24 | 2025-04-29 | 0.37 |
| 2025-04-16 | 2025-04-21 | 254.68 |
| 2025-03-18 | 2025-03-18 | 254.84 |
| 2025-02-18 | 2025-02-20 | 0.82 |
| 2025-01-22 | 2025-02-13 | 0.98 |
| 2025-01-20 | 2025-01-20 | 139.80 |
| 2024-11-20 | 2024-12-20 | 15.62 |
| 2024-10-24 | 2024-11-18 | 1.04 |
| 2024-10-16 | 2024-10-17 | 564.93 |
| 2024-09-17 | 2024-09-19 | 84.15 |
| 2024-08-21 | 2024-09-15 | 84.15 |
| 2024-07-29 | 2024-08-15 | 1.00 |
| 2024-07-24 | 2024-07-25 | 1.00 |
| 2024-07-16 | 2024-07-18 | 60.05 |
| 2024-05-16 | 2024-05-20 | 143.14 |
| 2024-04-23 | 2024-05-15 | 71.54 |
| 2024-04-16 | 2024-04-22 | 71.14 |
| 2024-01-23 | 2024-03-20 | 0.46 |
| 2024-01-16 | 2024-01-18 | 19.79 |
| 2023-11-16 | 2023-11-20 | 22.92 |
| 2023-10-25 | 2023-11-14 | 21.65 |
| 2023-10-17 | 2023-10-24 | 20.96 |
| 2023-09-19 | 2023-09-21 | 19.69 |
| 2023-09-18 | 2023-09-18 | 410.44 |
| 2023-08-17 | 2023-08-20 | 22.42 |
| 2023-07-27 | 2023-08-15 | 1.15 |
| 2023-07-24 | 2023-07-26 | 1.18 |
| 2023-07-18 | 2023-07-20 | 108.14 |
| 2023-06-19 | 2023-06-21 | 66.39 |
| 2023-06-16 | 2023-06-18 | 457.14 |
| 2023-05-16 | 2023-06-15 | 45.12 |
| 2023-05-02 | 2023-05-14 | 23.85 |
| 2023-04-27 | 2023-04-28 | 23.85 |
| 2023-04-26 | 2023-04-26 | 21.27 |
| 2023-04-25 | 2023-04-25 | 23.85 |
| 2023-04-18 | 2023-04-24 | 21.27 |
| 2023-03-27 | 2023-03-29 | 420.14 |
| 2023-03-16 | 2023-03-26 | 434.28 |
| 2023-02-21 | 2023-03-15 | 22.26 |
| 2023-02-17 | 2023-02-20 | 413.01 |
| 2023-02-06 | 2023-02-16 | 0.99 |
| 2023-01-20 | 2023-02-03 | 0.99 |
| 2022-11-21 | 2022-11-23 | 375.77 |
| 2022-11-17 | 2022-11-18 | 375.77 |
| 2022-10-28 | 2022-11-16 | 0.34 |
| 2022-10-18 | 2022-10-23 | 176.57 |
| 2022-07-18 | 2022-07-24 | 125.48 |
| 2022-06-16 | 2022-06-21 | 297.80 |
| 2022-05-17 | 2022-05-18 | 395.33 |
| 2022-04-25 | 2022-05-16 | 8.87 |
| 2022-04-19 | 2022-04-24 | 7.97 |
| 2022-02-17 | 2022-02-21 | 378.23 |
| 2021-12-16 | 2021-12-19 | 373.25 |
| 2021-11-16 | 2021-11-23 | 363.20 |
| 2021-10-18 | 2021-10-19 | 373.25 |
Dopamina - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Dopamina is: 1 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-28 | 2026-09-02 | 0.64 |
| 2026-08-17 | 2026-08-27 | 0.32 |
| 2026-08-09 | 2026-08-16 | 1.98 |
| 2026-08-02 | 2026-08-08 | 82.8 |
| 2026-07-16 | 2026-08-01 | 81.88 |
| 2026-06-19 | 2026-07-15 | 0.68 |
| 2026-05-19 | 2026-06-18 | 2.16 |
| 2026-05-17 | 2026-05-18 | 83.16 |
| 2026-05-01 | 2026-05-16 | 1.96 |
| 2026-04-30 | 2026-04-30 | 1.14 |
| 2026-04-19 | 2026-04-23 | 74.4 |
| 2026-04-17 | 2026-04-18 | 74.64 |
| 2026-04-01 | 2026-04-16 | 0.86 |
| 2026-03-24 | 2026-03-31 | 0.22 |
| 2026-03-22 | 2026-03-23 | 0.68 |
| 2026-03-18 | 2026-03-18 | 81.88 |
| 2026-02-27 | 2026-03-17 | 0.68 |
| 2026-02-18 | 2026-02-26 | 81.64 |
| 2026-02-03 | 2026-02-17 | 0.44 |
| 2026-01-31 | 2026-02-02 | 0.16 |
| 2026-01-17 | 2026-01-27 | 20.48 |
| 2025-02-02 | 2025-02-14 | 0.36 |
| 2025-01-31 | 2025-02-01 | 0.15 |
| 2025-01-01 | 2025-01-15 | 0.45 |
| 2024-12-31 | 2024-12-31 | 0.15 |
| 2024-12-19 | 2024-12-30 | 41.85 |
| 2024-12-03 | 2024-12-18 | 4.65 |
| 2024-12-01 | 2024-12-02 | 2.94 |
| 2024-11-01 | 2024-11-30 | 1.34 |
| 2024-10-01 | 2024-10-31 | 0.06 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dopamina, UAB (code 304112918) is a Private Limited Liability Company engaged in restaurant activities. In the latest financial year, 2025, the company generated revenue of €9.4K and reported a net loss of €1.0K, compared with a net profit of €100 in 2024 and €237 in 2023. This marks a sharp decline in performance after two years of low but positive results. Revenue also weakened significantly, falling 71.0% year on year and 64.7% over two years, after increasing from €26.7K in 2023 to €32.5K in 2024. The 2025 profit margin stood at -11.0%. At year-end 2025, total assets were €2.6K, equity was €2.6K, and liabilities were only €13, indicating a very small balance sheet with an equity ratio of 100.0%. Asset turnover was 3.63x. Productivity indicators were modest, with revenue per employee of €4.7K and a loss of €519 per employee. Overall, the company remained lightly capitalised and moved into loss in 2025 after a short period of minimal profitability.